Biotech · Private company
Emalex Biosciences Inc.
Track this companyFree. Adds Emalex Biosciences Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials151 recruiting or active
Pipeline programs25From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline25
- EcopipamPhase 3 · Tourette SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- EcopipamPhase 3 · Lesch-Nyhan DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Ecopipam HydrochloridePhase 3 · Tourette DisorderClinicalTrials.gov · fetched Nov 12, 2026
- EcopipamPhase 2 · Tourette's SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- EcopipamPhase 2 · Tourette Syndrome in ChildrenClinicalTrials.gov · fetched Nov 12, 2026
- EcopipamPhase 2 · Childhood-Onset Fluency Disorder (Stuttering)ClinicalTrials.gov · fetched Nov 12, 2026
- EcopipamPhase 2 · Pathological GamblingClinicalTrials.gov · fetched Nov 12, 2026
- 180 mg controlled release formPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- 90 mg controlled release formPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 1 Probe CocktailPhase 1 · Drug-InteractionsClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 1 Probe Substrate CocktailPhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 2 Probe CocktailPhase 1 · Drug-InteractionsClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 2 Probe SubstratePhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 3 Probe CocktailPhase 1 · Drug-InteractionsClinicalTrials.gov · fetched Nov 12, 2026
- Cohort 3 Probe Substrate CocktailPhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- Divalproex Sodium ERPhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- EcopipamPhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- ecopipam HCLPhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- ecopipam HCl ~2mg/kg/dayPhase 1 · Drug-InteractionsClinicalTrials.gov · fetched Nov 12, 2026
- Ecopipam HydrochloridePhase 1 · QT/QTcClinicalTrials.gov · fetched Nov 12, 2026
- Ecopipam immediate release formPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Ecopipam tabletPhase 1 · Food-effectClinicalTrials.gov · fetched Nov 12, 2026
- Mefenamic acidPhase 1 · Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- MoxifloxacinPhase 1 · QT/QTcClinicalTrials.gov · fetched Nov 12, 2026
- ecopipam HCl ~2mg/kg/dayTourettes DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- Food-effect Study of Ecopipam PharmacokineticsPHASE1 · COMPLETED · started Nov 5, 2024ClinicalTrials.gov NCT06669091 · fetched Nov 12, 2026
- A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's DisorderPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 16, 2023ClinicalTrials.gov NCT06021522 · fetched Nov 12, 2026
- Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac RepolarizationPHASE1 · COMPLETED · started Mar 15, 2023ClinicalTrials.gov NCT05841160 · fetched Nov 12, 2026
- Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and AdultsPHASE3 · COMPLETED · started Jan 31, 2023ClinicalTrials.gov NCT05615220 · fetched Nov 12, 2026
- Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and TransportPHASE1 · COMPLETED · started Apr 26, 2022ClinicalTrials.gov NCT05334108 · fetched Nov 12, 2026
- Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active MetabolitePHASE1 · COMPLETED · started May 13, 2021ClinicalTrials.gov NCT04902105 · fetched Nov 12, 2026
- Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple SubstratesPHASE1 · TERMINATED · started Feb 18, 2021ClinicalTrials.gov NCT04764851 · fetched Nov 12, 2026
- Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)PHASE2 · COMPLETED · started Oct 22, 2020ClinicalTrials.gov NCT04492956 · fetched Nov 12, 2026
- Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label ExtensionPHASE2 · COMPLETED · started Oct 4, 2019ClinicalTrials.gov NCT04114539 · fetched Nov 12, 2026
- Ecopipam Tablets to Study Tourette's Syndrome in Children and AdolescentsPHASE2 · COMPLETED · started Jun 28, 2019ClinicalTrials.gov NCT04007991 · fetched Nov 12, 2026
- Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 YearsPHASE2 · COMPLETED · started Jun 19, 2014ClinicalTrials.gov NCT02102698 · fetched Nov 12, 2026
- Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan DiseasePHASE3 · TERMINATED · started Dec 1, 2012ClinicalTrials.gov NCT01751802 · fetched Nov 12, 2026
- Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of EcopipamPHASE1 · COMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01408394 · fetched Nov 12, 2026
- Clinical Study to Determine if Ecopipam Can Reduce Urges to GamblePHASE2 · COMPLETED · started Oct 1, 2010ClinicalTrials.gov NCT01215357 · fetched Nov 12, 2026
- Expanded Access Program for Treatment With Ecopipam for Tourette's DisorderNO_LONGER_AVAILABLEClinicalTrials.gov NCT07093541 · fetched Nov 12, 2026